194 related articles for article (PubMed ID: 25260311)
1. Integration of genomic information in the clinical management of HCC.
Quetglas IM; Moeini A; Pinyol R; Llovet JM
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):831-42. PubMed ID: 25260311
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of liver tumors: classification and clinical translation for decision making.
Pinyol R; Nault JC; Quetglas IM; Zucman-Rossi J; Llovet JM
Semin Liver Dis; 2014 Nov; 34(4):363-75. PubMed ID: 25369299
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
4. Molecular perspectives for the treatment of hepatocellular carcinoma.
Demory A; Nault JC
Acta Gastroenterol Belg; 2020; 83(2):309-312. PubMed ID: 32603051
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
Marquardt JU; Galle PR; Teufel A
J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
[TBL] [Abstract][Full Text] [Related]
6. Gene signatures in the management of hepatocellular carcinoma.
Hoshida Y; Moeini A; Alsinet C; Kojima K; Villanueva A
Semin Oncol; 2012 Aug; 39(4):473-85. PubMed ID: 22846864
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in hepatocellular carcinoma: An update.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
[TBL] [Abstract][Full Text] [Related]
8. Comparative and integrative functional genomics of HCC.
Lee JS; Thorgeirsson SS
Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
[TBL] [Abstract][Full Text] [Related]
9. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma.
Akula SM; Abrams SL; Steelman LS; Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; Cervello M; McCubrey JA
Expert Opin Ther Targets; 2019 Nov; 23(11):915-929. PubMed ID: 31657972
[No Abstract] [Full Text] [Related]
10. Genetic profiling of human hepatocellular carcinoma.
Lee JS; Thorgeirsson SS
Semin Liver Dis; 2005; 25(2):125-32. PubMed ID: 15918141
[TBL] [Abstract][Full Text] [Related]
11. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
[TBL] [Abstract][Full Text] [Related]
12. Biology of Hepatocellular Carcinoma.
Critelli RM; De Maria N; Villa E
Dig Dis; 2015 Sep; 33(5):635-41. PubMed ID: 26398186
[TBL] [Abstract][Full Text] [Related]
13. [microRNA: new diagnostic and therapeutic tools in liver disease?].
Gougelet A; Colnot S
Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
[TBL] [Abstract][Full Text] [Related]
14. TERT promoter mutations in primary liver tumors.
Nault JC; Zucman-Rossi J
Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):9-14. PubMed ID: 26336998
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of hepatocellular carcinoma.
Cornellà H; Alsinet C; Villanueva A
Alcohol Clin Exp Res; 2011 May; 35(5):821-5. PubMed ID: 21303380
[TBL] [Abstract][Full Text] [Related]
16. OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma.
Ueno A; Masugi Y; Yamazaki K; Komuta M; Effendi K; Tanami Y; Tsujikawa H; Tanimoto A; Okuda S; Itano O; Kitagawa Y; Kuribayashi S; Sakamoto M
J Hepatol; 2014 Nov; 61(5):1080-7. PubMed ID: 24946283
[TBL] [Abstract][Full Text] [Related]
17. Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle.
Bhoori S; Toffanin S; Sposito C; Germini A; Pellegrinelli A; Lampis A; Mazzaferro V
J Hepatol; 2010 May; 52(5):771-5. PubMed ID: 20347502
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive genome sequencing of the liver cancer genome.
Nakagawa H; Shibata T
Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
[TBL] [Abstract][Full Text] [Related]
19. [Genomic prognostic markers in hepatocellular carcinoma].
Alsinet C; Villanueva A
Gastroenterol Hepatol; 2012 Feb; 35(2):94-101. PubMed ID: 22178501
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies.
Zucman-Rossi J; Laurent-Puig P
Pharmacogenomics; 2007 Aug; 8(8):997-1003. PubMed ID: 17716233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
